• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER VENA VENOUS SELF-EXPANDING STENT; NIO STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER VENA VENOUS SELF-EXPANDING STENT; NIO STENT, ILIAC Back to Search Results
Model Number G57449
Device Problems Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/10/2021
Event Type  malfunction  
Manufacturer Narrative
Pma/510(k) # p200023.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Per rep 11mar2021: after the physician deployed the stent in the left iliac, the 1st 75 % of the proximal stent deployed well and fully open.Then the distal 25 % of the stent did not fully open and remained compressed.After seeing this, the physician tried to balloon that part of the stent multiple times but each time, after ballooning, the stent would just compress again.After this, the physician had to line the inside of the stent with a competitive stent.8fr sheath used rather than the recommended 7fr no adverse effect reported as a result of this occurrence examples of rpn prefixes (but not limited to): zib5, zib6, ziv5, zisv6, zvt7, ziv6.General questions for complaint occurring during use, request the following: where was the access site?: left groin.What was the patient¿s anatomy? i.E.Scarred, tortuous, calcified, etc.: somewhat tortuous, possibly scarred.What was the target location for the stent?: left iliac.Was the target location severely calcified or tortuous?: tortuous.Was the device flushed prior to use?: yes.Were there any difficulties deploying the stent?: no.Was the stent fully deployed before removing the delivery system from the patient?: yes.What other devices were used in the procedure?: phillips ivus, a bard atlas balloon, wires, 8fr sheath.Please provide manufacturer, model, brand, and size if possible.: phillips ivus, a bard atlas balloon, wires, 8fr sheath.Were any additional procedures necessary as a result of this event?: no.Can any photos, images, or reports of the procedure or device be provided?: no.Please review following ¿failure¿ modes with contact to determine if additional questions apply.If the event involves thombosis, restenosis, and/or occlusion, request the following: n/a.Did the patient have any risk factors for thrombosis, restenosis, or occlusion? what other medications and/or treatments was the patient receiving? if occlusion occurred, can it be confirmed if the occlusion is related to thrombosis or restenosis? if the event involved claudication / pain, request the following: is the reported event a symptom of restenosis or thrombosis?: no.If no restenosis or thrombosis occurred how it was determined that the zilver stents caused / contributed to the event?: the stent would not fully open.If the event involves stent shortening, request the following: n/a.Was there any evidence of post deployment stent compression or deformation? was the delivery system able to be advanced to the target site easily / with no resistance? was the handle pulled toward the hub while the delivery system remained stationary during deployment? if the event involves sheath separation, request the following: n/a.Was there high resistance encountered during any part of the procedure, wire guide advancement, stent deployment, etc.? was pre-dilatation conducted prior to stent deployment? was the handle puled toward the hub while the delivery system remained stationary during deployment? if the event involving deployment difficulties, request the following: n/a.Was the stent eventually deployed? was pre-dilatation conducted before stent deployment? was the handle pulled toward the hub while the delivery system remained stationary during deployment? if the event that involve device stuck on wire guide, difficult to advance / remove delivery system and/or wire guide, request the following: n/a.Was the wire guide hydrophilic or non-hydrophilic? how long was the procedure 0from advancing delivery system to the moment when the user attempted to remove the device? was the wire guide new or was the wire guide used previously before advancing the zilver delivery system? if used, was the wire guide wiped between uses? was the device used percutaneously? n/a,yes,no: yes.Where on the patient was the percutaneous access site?: groin.What disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other?: chronic obstruction.If other, please specify was the lesion approached via contralateral or ipsilateral? n/a, contralateral, ipsilateral: ipsilateral.Was pre-dilation performed ahead of placement of the stent? n/a, yes, no: yes.Did the user remove slack in the delivery system before deployment, per ifu? n/a, yes, no: yes.Was the delivery system damaged/kinked/twisted during deployment? n/a, yes, no: no.Please specify if yes.N/a.
 
Manufacturer Narrative
Pma/510(k) # p200023, device evaluation the zvt7-35-80-16-140 device of c1769826 lot number involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document-based investigation was conducted.This complaint is related to (b)(4).Which captures the stent remaining compressed on deployment.Lab evaluation ¿ n/a.Document review.Prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records revealed a non-conformance for embedded fm (pac-002) was noted on this work order however this could not have contributed to this complaint issue.The review of the relevant manufacturing records confirms the failure mode has not previously occurred for this work order.It should be noted that the instructions for use states the following: ¿for venous access, the use of an access set that accepts a 2.3mm (7.0 french) introducer catheter is recommended¿.There is evidence to suggest that the customer did not follow the instructions for use or label.Image review.An image was not returned for evaluation.Root cause review.A definitive root cause of the user not reading or following the instructions for use has been determined.From the additional questions it is known that an access sheath that accepts an 8fr introducer catheter was used with the device.As previously noted, the ifu states ¿for venous access, the use of an access set that accepts a 2.3mm (7.0 french) introducer catheter is recommended¿.Summary.The complaint is confirmed based on customer testimony.According to the initial reporter, the patient did not experience any adverse effects as a result of this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental follow-up mdr report is being submitted due to the completion of the investigation and an update to the investigation conclusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER VENA VENOUS SELF-EXPANDING STENT
Type of Device
NIO STENT, ILIAC
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key16662887
MDR Text Key313530112
Report Number3001845648-2023-00210
Device Sequence Number1
Product Code NIO
UDI-Device Identifier10827002574493
UDI-Public(01)10827002574493(17)231021(10)C1769826
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/21/2023
Device Model NumberG57449
Device Catalogue NumberZVT7-35-80-16-140
Device Lot NumberC1769826
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/10/2021
Event Location Hospital
Date Manufacturer Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/21/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-